Metabolic Fingerprinting Uncovers the Distinction Between the Phenotypes of Tuberculosis Associated COPD and Smoking-Induced COPD

Frontiers in Medicine

Joo-Youn Cho¹  Da Jung Kim²  Chin Kook Rhee³  Seoung Ju Park⁴  Jae Jeong Shim⁵  Jee Youn Oh⁵ 

[1] Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea;Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea;Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea;Seoul National University Medical Research Center, Seoul National University College of Medicine and Hospital, Seoul, South Korea;Division of Pulmonary Medicine, Department of Internal Medicine, Catholic University Seoul Hospital, Seoul, South Korea;Division of Pulmonary Medicine, Department of Internal Medicine, Chonbuk National University Hospital, Jeonju, South Korea;Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea;

关键词: chronic obstructive pulmonary disease;    tuberculosis;    metabolomics;    biomarker;    smoking;   

DOI  :  10.3389/fmed.2021.619077

来源: Frontiers

【 授权许可】

CC BY